Global Nystatin API Market Growth 2025-2031

Publication ID:

LPI02259807

Publication Date:

February 20, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Nystatin API market size is predicted to grow from US$ 35.2 million in 2025 to US$ 43.6 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Nystatin API (Active Pharmaceutical Ingredient) is the raw material of a polyene - type antifungal drug. It is extracted from the culture broth of Streptomyces noursei and its main component is nystatin. It is a complex compound that belongs to the macrolide antibiotics family and has a conjugated polyene structure.
United States market for Nystatin API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Nystatin API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Nystatin API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Nystatin API players cover Antibiotice, Centrient Pharmaceuticals, Duchefa Farma, VUAB Pharma, Hubei Hengshuo Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淣ystatin API Industry Forecast鈥� looks at past sales and reviews total world Nystatin API sales in 2024, providing a comprehensive analysis by region and market sector of projected Nystatin API sales for 2025 through 2031. With Nystatin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nystatin API industry.
This Insight Report provides a comprehensive analysis of the global Nystatin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nystatin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Nystatin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nystatin API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nystatin API.
This report presents a comprehensive overview, market shares, and growth opportunities of Nystatin API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nystatin Non-micronized
Nystatin Micronized
Nystatin Compacted
Segmentation by Application:
External Preparations
Oral Preparations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Antibiotice
Centrient Pharmaceuticals
Duchefa Farma
VUAB Pharma
Hubei Hengshuo Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nystatin API market?
What factors are driving Nystatin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nystatin API market opportunities vary by end market size?
How does Nystatin API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nystatin API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Nystatin API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Nystatin API by Country/Region, 2020, 2024 & 2031
2.2 Nystatin API Segment by Type
2.2.1 Nystatin Non-micronized
2.2.2 Nystatin Micronized
2.2.3 Nystatin Compacted
2.3 Nystatin API Sales by Type
2.3.1 Global Nystatin API Sales Market Share by Type (2020-2025)
2.3.2 Global Nystatin API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Nystatin API Sale Price by Type (2020-2025)
2.4 Nystatin API Segment by Application
2.4.1 External Preparations
2.4.2 Oral Preparations
2.5 Nystatin API Sales by Application
2.5.1 Global Nystatin API Sale Market Share by Application (2020-2025)
2.5.2 Global Nystatin API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Nystatin API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Nystatin API Breakdown Data by Company
3.1.1 Global Nystatin API Annual Sales by Company (2020-2025)
3.1.2 Global Nystatin API Sales Market Share by Company (2020-2025)
3.2 Global Nystatin API Annual Revenue by Company (2020-2025)
3.2.1 Global Nystatin API Revenue by Company (2020-2025)
3.2.2 Global Nystatin API Revenue Market Share by Company (2020-2025)
3.3 Global Nystatin API Sale Price by Company
3.4 Key Manufacturers Nystatin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nystatin API Product Location Distribution
3.4.2 Players Nystatin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Nystatin API by Geographic Region
4.1 World Historic Nystatin API Market Size by Geographic Region (2020-2025)
4.1.1 Global Nystatin API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Nystatin API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nystatin API Market Size by Country/Region (2020-2025)
4.2.1 Global Nystatin API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Nystatin API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nystatin API Sales Growth
4.4 APAC Nystatin API Sales Growth
4.5 Europe Nystatin API Sales Growth
4.6 Middle East & Africa Nystatin API Sales Growth
5 Americas
5.1 Americas Nystatin API Sales by Country
5.1.1 Americas Nystatin API Sales by Country (2020-2025)
5.1.2 Americas Nystatin API Revenue by Country (2020-2025)
5.2 Americas Nystatin API Sales by Type (2020-2025)
5.3 Americas Nystatin API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nystatin API Sales by Region
6.1.1 APAC Nystatin API Sales by Region (2020-2025)
6.1.2 APAC Nystatin API Revenue by Region (2020-2025)
6.2 APAC Nystatin API Sales by Type (2020-2025)
6.3 APAC Nystatin API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nystatin API by Country
7.1.1 Europe Nystatin API Sales by Country (2020-2025)
7.1.2 Europe Nystatin API Revenue by Country (2020-2025)
7.2 Europe Nystatin API Sales by Type (2020-2025)
7.3 Europe Nystatin API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nystatin API by Country
8.1.1 Middle East & Africa Nystatin API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Nystatin API Revenue by Country (2020-2025)
8.2 Middle East & Africa Nystatin API Sales by Type (2020-2025)
8.3 Middle East & Africa Nystatin API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nystatin API
10.3 Manufacturing Process Analysis of Nystatin API
10.4 Industry Chain Structure of Nystatin API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nystatin API Distributors
11.3 Nystatin API Customer
12 World Forecast Review for Nystatin API by Geographic Region
12.1 Global Nystatin API Market Size Forecast by Region
12.1.1 Global Nystatin API Forecast by Region (2026-2031)
12.1.2 Global Nystatin API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nystatin API Forecast by Type (2026-2031)
12.7 Global Nystatin API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Antibiotice
13.1.1 Antibiotice Company Information
13.1.2 Antibiotice Nystatin API Product Portfolios and Specifications
13.1.3 Antibiotice Nystatin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Antibiotice Main Business Overview
13.1.5 Antibiotice Latest Developments
13.2 Centrient Pharmaceuticals
13.2.1 Centrient Pharmaceuticals Company Information
13.2.2 Centrient Pharmaceuticals Nystatin API Product Portfolios and Specifications
13.2.3 Centrient Pharmaceuticals Nystatin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Centrient Pharmaceuticals Main Business Overview
13.2.5 Centrient Pharmaceuticals Latest Developments
13.3 Duchefa Farma
13.3.1 Duchefa Farma Company Information
13.3.2 Duchefa Farma Nystatin API Product Portfolios and Specifications
13.3.3 Duchefa Farma Nystatin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Duchefa Farma Main Business Overview
13.3.5 Duchefa Farma Latest Developments
13.4 VUAB Pharma
13.4.1 VUAB Pharma Company Information
13.4.2 VUAB Pharma Nystatin API Product Portfolios and Specifications
13.4.3 VUAB Pharma Nystatin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 VUAB Pharma Main Business Overview
13.4.5 VUAB Pharma Latest Developments
13.5 Hubei Hengshuo Chemical
13.5.1 Hubei Hengshuo Chemical Company Information
13.5.2 Hubei Hengshuo Chemical Nystatin API Product Portfolios and Specifications
13.5.3 Hubei Hengshuo Chemical Nystatin API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hubei Hengshuo Chemical Main Business Overview
13.5.5 Hubei Hengshuo Chemical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂